Article and Video CATEGORIES

Cancer Journey

Search By

Women, Tamoxifen, and Lung Cancer
Author
Dr. Pinder

One of my areas of interest is studying gender-related differences in lung cancer. Earlier this year, I wrote a post about interesting data that had come out of the Women’s Health Initiative study. This was the landmark study that established that hormone replacement therapy (HRT) for postmenopausal women did more harm than good. When originally presented in 2002, the investigators noted significantly increased risks of breast cancer, cardiovascular disease and stroke. At ASCO 2009, they also reported an increase in lung cancer incidence and lung cancer mortality among postemenopausal women who received HRT compared to those who received placebo.

tamox-post-figure-1(click on image to enlarge)

tamox-post-figure-2

This data got some researchers in Switzerland thinking. If estrogens increased the risk of lung cancer, would anti-estrogens decrease the risk of lung cancer? Who is taking anti-estrogens? Women with breast cancer. So the researchers studied almost 7,000 breast cancer patients in the Geneva Cancer Registry. About half of these women took tamoxifen, an anti-estrogen used to decrease the risk of breast cancer relapse and also for breast cancer prevention. Findings from the study were recently presented at the annual San Antonio Breast Cancer Symposium. The investigators identified a strong trend towards decreased incidence of lung cancer in breast cancer survivors on tamoxifen (p = .058) and a significant decrease in the risk of death from lung cancer among women taking tamoxifen (p < .0001). The authors compared incidence of lung cancer and death from lung cancer among the two groups of breast cancer survivors. They also compared the findings in each group to expected lung cancer incidence and death in an age-matched population without breast cancer. Not only did the breast cancer patients on tamoxifen experience lower lung cancer mortality than the other breast cancer patients, their rates were lower than would be expected in a healthy population.

Although there was a trend towards lower lung cancer incidence, tamoxifen appeared to have a bigger impact on mortality from lung cancer. This suggests that even with a diagnosis of lung cancer, tamoxifen may have an effect on the biology of the cancer such that fewer women died of their disease.

This line of thinking is not new. We have known for some time that normal lung tissue and lung cancer cells express estrogen receptors and thus have the potential to be affected by estrogen, which can actually be produced in the lung. While women as a whole have a better prognosis compared to men, premenopausal women do not seem to have the same favorable prognosis. Higher blood estrogen levels have been associated with worse outcomes in men and women compared to those with lower levels and animal studies have shown that anti-estrogens can shrink lung tumors.

Patients have asked me if they should stop taking their HRT after a diagnosis of lung cancer and I have generally encouraged this. But I still can’t answer the question of whether anti-estrogens will be helpful in the treatment of lung cancer. This study, though intriguing, was retrospective and we don’t know whether there was a confounding factor that accounted for the benefit in terms of lung cancer mortality in women on tamoxifen. For example, could women have been taking another medication for tamoxifen side effects (notorious hot flashes) that might have been the real driving factor behind the benefit seen? There are some clinical trials which will be looking more closely at anti-estrogen therapy in lung cancer patients. Until then, though, I don’t feel that hypothesis-generating data we have justifies the use of anti-estrogens, particularly given substantial side effects.

In addition to estrogen’s direct effect on lung cancer cells, we have laboratory studies which suggests interactions between the estrogen receptor and other pathways involved in lung cancer progression, such as EGFR. Tarceva is currently being studied in combination with a different anti-estrogen (Faslodex) and I anticipate other studies in this vein.

If you are interested, more references and information on lung cancer in women can be found in a presentation I recently gave for patients, available here:

dr-pinder-women-and-lung-cancer-slide-presentation

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...

Hi Bluebird,  Welcome to GRACE.  I'm sorry you're going through this scare and hope it's just inflammation or from an infection you didn't know you had. 

 

A CT would be...

Radiation + Brain Operation has just been discarded due to high risk. They will double Tagrisso dosis and then wait to see if it works, then try traditional Chemo. I would...

Hi and welcome to GRACE.  I'm sorry to know you are entering a new stage.  I'm not about to comment just now but wanted to let you know I see your...

Edit to say, we can't give advice but we can comment with views and facts.  :)

 

My first thought is to ask if she has been seen at a large...

Hi Barbro, Welcome to GRACE. I'm sorry you're worrying about this. We aren't able to give feedback on scan reports. Interpreting scan reports in this setting is not only unethical but...

Recent Comments

JOIN THE CONVERSATION
Tagrix FDA Approval
By mariachristian on
Hi Judy! It is so good to…
By JanineT GRACE … on
Tagrix vs Tagrisso
By Dipakchavan on
Hello Linda, my name is…
By AlexandraGBeneke on